A proposal to delay the EU MDR gets approved

Richard Jones
EU flag

A vote in the European Parliament has decisively approved a delay to full implementation of the EU’s MDR by one year, allowing the medical device industry to prioritise its Covid-19 response efforts.

The EU MDR implementation date was set for 26th May 2021. However in light of this coronavirus pandemic and with an urgent need for medical device manufacturers to help supply much needed equipment to resource-stretched hospitals, a proposal crafted by the European Commission received an approval — 693 votes in favour, 1 against, and 2 abstentions — to push back the implementation date.

This delay will be welcomed by some companies that were not ready for the switch-over, and it offers more time to take stock, zoom out and re-assess their regulatory strategy. We offered 5 tips to make best use of more time that might help in such a re-evaluation.

Related articles

  1. MEDICA 2024

    Mantra Systems at MEDICA 2024

    Mantra Systems is going to MEDICA 2024, the largest medical trade fair in the world. We hope to see you there.

    Richard Jones Richard Jones Operations Director
  2. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  3. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  4. MEDICA 2023

    Mantra Systems at MEDICA 2023

    Mantra Systems is going to MEDICA 2023, the largest medical trade fair in the world. We hope to see you there.

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  5. MDR Compliance Webinar - A masterclass on building a winning EU MDR strategy for your medical devices

    Build a winning EU MDR strategy for your medical devices

    Watch our CEO, Dr Paul Hercock, deliver a Mantra Systems webinar on MDR compliance strategy.

    Richard Jones Richard Jones Operations Director
  6. Simplifying the challenges posed by the new EU MDR

    Simplifying the challenges posed by the new EU MDR

    Our CEO Dr Paul Hercock was invited to speak on a Kaizen Life Sciences podcast about the challenges posed by the EU MDR.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  7. EU regulators may delay MDR enforcement

    EU regulators may delay MDR enforcement. Out of the woods?

    A delay of the MDR would be welcome news for many, but what would a delay mean in practice? To what extent can preparations for EU MDR be put on ice?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Enquire today

Close

Let's talk

Send an enquiry or book a free discovery meeting to see how we can support your market access strategy